Explain this page
Arphra AIPlain-English read on Biogen Inc.’s valuationCompany profile
DB · companies + sec_company_profileBiogen Inc. (BIIB) — the SEC company profile (description, website, HQ) has not been loaded for this ticker yet. Run the SEC profile loader to populate it.
AI description
Arphra AILoading cached description…
Identifiers
- SymbolBIIB
- Legal nameBiogen Inc.
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CountryUS
- CurrencyUSD
- ExchangeNASDAQ
- CIK0000875045
- ISIN—
- CUSIP—
- LEI—
- Employees—
Trading
DB · key_metrics_ttmMay 02, 2026- Market cap$27.62B
- P/E (TTM)—
- P/B—
- EV / EBITDA—
- Dividend yield—
Identifiers
OpenFIGI · GLEIFCross-source keys used to bridge market-data, SEC, and non-US sources.
- FIGIBBG000C17X76
- CountryUS
Key executives
DB · executives| Name | Title | Compensation | Born | Since |
|---|---|---|---|---|
| Christopher A. Viehbacher | President, Chief Executive Officer & Director | $6.15M | 1961 | — |
| Susan H. Alexander | Executive Vice President & Chief Legal Officer | $2.63M | 1957 | — |
| Robin C. Kramer | Executive Vice President & Chief Financial Officer | $2.21M | 1966 | — |
| Priya Singhal | Executive Vice President & Head of Development | $1.95M | 1969 | — |
| Nicole Murphy | Executive Vice President and Head of Pharmaceutical Operations & Technology | $1.86M | 1973 | — |
| Ginger Gregory | Executive Vice President & Chief Human Resources Officer | $1.59M | 1968 | — |
| Tim Power | Head of Investor Relations | — | — | — |
| Alisha A. Alaimo | President & Head of North America | — | — | — |